Moreover, T2DM patients with lower methylation levels in NLRP3 CpG2, NLRP3 CpG3, AIM2 CpG2, and ASC methylation levels were more susceptible to developing macrovascular complications (P < 0.05). The gene discussed is AIM2; the disease is type 2 diabetes mellitus.